Diphthamide Biosynthesis 7 (DPH7) (AA 210-325) Antikörper (FITC)
Kurzübersicht für Diphthamide Biosynthesis 7 (DPH7) (AA 210-325) Antikörper (FITC) (ABIN7150007)
Target
Alle Diphthamide Biosynthesis 7 (DPH7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 210-325
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Diphthine methyltransferase protein (210-325AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Diphthamide Biosynthesis 7 (DPH7)
-
Andere Bezeichnung
- DPH7
-
Hintergrund
-
Background: Catalyzes the demethylation of diphthine methyl ester to form diphthine, an intermediate diphthamide biosynthesis, a post-translational modification of histidine which occurs in translation elongation factor 2 (EEF2) which can be ADP-ribosylated by diphtheria toxin and by Pseudomonas exotoxin A (Eta).
Aliases: C9orf112 antibody, Diphthamide biosynthesis 7 antibody, DPH7 antibody, FLJ90634 antibody, OTTHUMP00000022705 antibody, RP11-48C7.3 antibody, RRT2 antibody, WD repeat domain 85 antibody, WD repeat-containing protein 85 antibody, wdr85 antibody, WDR85_HUMAN antibody
-
UniProt
- Q9BTV6
Target
-